#Kisunla
Myra Solano Garcia, who has Alzheimer's, says the drug Kisunla may be one reason she can still drive, cook, and sing.
Alzheimer's was taking her memory, so she started taking a new drug
Myra Solano Garcia, who has Alzheimer's, says the drug Kisunla may be one reason she can still drive, cook, and sing.
www.npr.org
February 28, 2025 at 12:10 AM
My guess would be a monthly Alzheimer's infusion, either Leqembi or Kisunla.
May 2, 2026 at 10:48 PM
Reminding everyone again that monthly infusions of Kisunla are standard treatment for Alzheimer’s right now.
The discolored area on the back of Trump's right hand seems to be getting larger and approaching his fingers. This photo was taken today as he spoke to reporters in Florida. (Roberto Schmidt/Getty)
April 25, 2026 at 9:45 PM
As I suspected. An MRI is needed to monitor Kisunla - a treatment for Alzheimer’s.
www.cnn.com/2025/10/27/p...
October 27, 2025 at 2:39 PM
Real answer: Trump receives Lecanemab (Leqembi) or Donanemab (Kisunla) via IV infusion in an effort to slow his cognitive loss due to his dementia.
Q: Can you explain what's going on with the bandages on Trump's hand?

LEAVITT: We've given you an explanation. The president is literally constantly shaking hands.
December 11, 2025 at 9:48 PM
Heard this on a Pharmaceutical commercial:
“If you’re allergic to Kisunla then don’t take Kisunla” 🤔
("PharmaSuitAbles 2025", 26"x38.4", charcoal & graphite on paper, ©LaurieLipton)
May 2, 2026 at 1:32 PM
FYI- Kisunla (early alzheimer's medication) is administered via IV every 4 weeks 🤔
April 4, 2026 at 6:58 PM
IV bruising. Kisunla Rx for Alzheimer’s, possibly?
January 22, 2026 at 4:10 PM
Lecanemab (Leqembi) & donanemab (Kisunla) are antiamyloid medicines approved for people with mild dementia due to Alzheimer's disease & mild cognitive impairment due to AD. Lecanemab is given as an IV infusion every 2 weeks. Donanemab is given as an IV infusion every 4 weeks.

Neither cures.
February 25, 2025 at 2:35 AM
Kisunla.
February 25, 2025 at 2:53 AM
Or the IV treatments for dementia/Parkinson’s (lecanemab (Leqembi) and donanemab (Kisunla)) that require infusion every 2 weeks…
July 15, 2025 at 10:45 PM
Kisunla injection?
February 25, 2025 at 3:14 AM
It’s once a month, consistent with infusions of Kisunla for early stage Alzheimer’s. Infusions are made through the front of the hand.
May 7, 2026 at 5:14 PM
How about depends tRump memorial field?
Or maybe tRump Kisunla (Alzheimers med) stadium?
November 9, 2025 at 12:32 AM
I’m begging a reporter to make a spreadsheet of the dates he shows up with this. I’m telling you it’s once a month, consistent with infusions of Kisunla for early stage Alzheimer’s.

(I may do this myself if some hotshot doesn’t take me up on it.)
I don't know why anyone thinks he makes it to 2028.
May 6, 2026 at 11:18 PM
More specifically an infusion, either Kisunla or Leqembi
December 5, 2025 at 9:03 PM
Kisunla, a dementia drug by Eli Lilly, is administered by IV, and also

- requires frequent MRIs to check for fatal brain bleeds
- has “difficulty walking” and “confusion” as listed side effects

kisunla.lilly.com
December 3, 2025 at 10:20 PM
Kisunla. I’m convinced. It’s a monthly infusion for dementia. Can cause small brain bleeds or edema, explaining his mystery MRI, facial droop, dragging his right leg, speech, etc.
December 10, 2025 at 5:19 AM
Just saw an explanation that Trump is getting monthly IV Kisunla treatments meant for Alzheimer's patients. And that he has 6 months to live. And I'm going to just accept that as complete truth.
December 5, 2025 at 2:46 AM
Likely an Alzheimer’s med like Kisunla.
April 27, 2026 at 8:57 PM
The monthly hand bandage (kisunla), the MRI, the oval office sign, the rambling. The President has Alzheimer's.

But rich people are getting what they want, so I guess we're going to pretend he doesn't.
December 6, 2025 at 2:59 PM
Leqembi or Kisunla🧠 won't prevent his heart or kidneys from inching him closer to the grave, fortunately (but unfortunately).
May 26, 2026 at 11:15 PM
In case you know someone taking MRIs 6 months apart.

Kisunla (generic name: donanemab-azbt) is a monoclonal antibody medication developed by Eli Lilly and Company for the treatment of early-stage symptomatic Alzheimer's disease, including mild cognitive impairment or mild dementia.
November 18, 2025 at 4:05 AM
“This dementia patient has three to five months left to live”—The educated opinion of a physical therapist with a doctorate in his field.

I’m pulling for an early Christmas present for the world.

#Pink #ProudBlue #tRumpStroke #Kisunla
December 5, 2025 at 1:29 PM